Gary Loeb Sells 400 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $446.95, for a total transaction of $178,780.00. Following the transaction, the executive vice president owned 6,120 shares of the company’s stock, valued at approximately $2,735,334. The trade was a 6.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $431.87 on Wednesday. The firm’s 50-day moving average is $467.90 and its two-hundred day moving average is $516.36. The company has a market capitalization of $152.95 billion, a PE ratio of 52.35, a price-to-earnings-growth ratio of 3.35 and a beta of 1.51. Intuitive Surgical, Inc. has a 12-month low of $417.74 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same period last year, the company posted $1.81 EPS. The company’s revenue was up 23.0% on a year-over-year basis. On average, analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Hedge Funds Weigh In On Intuitive Surgical

Several institutional investors have recently added to or reduced their stakes in ISRG. Brighton Jones LLC grew its holdings in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after buying an additional 731 shares during the period. Sivia Capital Partners LLC increased its stake in shares of Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after acquiring an additional 34 shares during the last quarter. Schnieders Capital Management LLC. lifted its holdings in shares of Intuitive Surgical by 38.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after acquiring an additional 268 shares during the period. Osterweis Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the second quarter worth approximately $200,000. Finally, Main Street Financial Solutions LLC boosted its position in shares of Intuitive Surgical by 92.4% in the second quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock worth $1,592,000 after acquiring an additional 1,407 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently issued reports on ISRG. HSBC reduced their price objective on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. TD Cowen dropped their price objective on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Barclays set a $651.00 target price on shares of Intuitive Surgical and gave the company an “overweight” rating in a report on Thursday, April 23rd. Argus decreased their price target on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Finally, Raymond James Financial lowered their price target on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a report on Wednesday, April 22nd. Eighteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $581.91.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: The stock may be due for a rebound after falling into oversold territory, with Wall Street analysts broadly revising earnings estimates higher. Article Title
• Positive Sentiment: Industry commentary highlighted continued growth in surgical robotics, citing rising procedure volumes and system installations as supportive for Intuitive Surgical’s long-term outlook. Article Title
• Positive Sentiment: Recent earnings strength remains a key positive, as Intuitive Surgical beat expectations with $2.77 billion in revenue and 431 da Vinci system installations globally. Article Title
• Neutral Sentiment: Multiple bullish articles argued that Intuitive Surgical’s competitive moat is strengthening, reinforcing the company’s premium valuation case. Article Title
• Neutral Sentiment: EVP Gary Loeb sold 400 shares under a pre-arranged 10b5-1 plan, which is notable but limited in size and not necessarily a fundamental signal. Article Title
• Negative Sentiment: Investor sentiment has been hurt by FDA scrutiny of the SureForm stapler reload issue, which was classified as a Class I recall and adds product-safety overhang. Article Title
• Negative Sentiment: Reports of institutional selling and a recent drop toward a 52-week low have reinforced concerns that valuation and safety headlines are pressuring the stock. Article Title

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.